⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Axis Large Cap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Axis MF | HDFC MF |
| Category | Equity - Large Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹67.29 (29 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | BSE 100 - TRI | BSE Health Care - TRI |
| Fund Manager | Shreyash Devalkar | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | -6.66% | 22.64% |
| 3Y | 9.30% | 30.41% |
| 5Y | 5.14% | — |
| Since Inception | 13.15% | 29.15% |
| Risk | ||
| 12.28 | 14.07 | |
| 0.95 | 0.59 | |
| 0.16 | 1.59 | |
| 1.62 | 21.67 | |
| 0.27 | 3.48 | |
| -12.11% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.94% | 1.03% |
| Exit Load | NIL | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹500 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Axis MF92%
HDFC MF92%
8.2%Only 8.2% of holdings by weight are common between Axis MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingAxis MFHDFC MF
Apollo Hospitals Enterprise Ltd.2.91%3.69%
Divi's Laboratories Ltd.2.72%9.39%
Sun Pharmaceutical Industries Ltd.2.56%8.28%
Category context: Equity vs Equity. Open the full Screener →